These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 11727260

  • 1. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma.
    Rioux-Leclercq N, Epstein JI, Bansard JY, Turlin B, Patard JJ, Manunta A, Chan T, Ramee MP, Lobel B, Moulinoux JP.
    Hum Pathol; 2001 Nov; 32(11):1209-15. PubMed ID: 11727260
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
    Yildiz E, Gokce G, Kilicarslan H, Ayan S, Goze OF, Gultekin EY.
    BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
    [Abstract] [Full Text] [Related]

  • 3. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY.
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [Abstract] [Full Text] [Related]

  • 4. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
    Gelb AB, Sudilovsky D, Wu CD, Weiss LM, Medeiros LJ.
    Cancer; 1997 Nov 01; 80(9):1768-75. PubMed ID: 9351546
    [Abstract] [Full Text] [Related]

  • 5. Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma.
    Imao T, Egawa M, Takashima H, Koshida K, Namiki M.
    Int J Urol; 2004 Nov 01; 11(11):948-53. PubMed ID: 15509196
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma.
    Joo HJ, Oh DK, Kim YS, Lee KB, Kim SJ.
    BJU Int; 2004 Feb 01; 93(3):291-6. PubMed ID: 14764125
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma.
    Ebru T, Fulya OP, Hakan A, Vuslat YC, Necdet S, Nuray C, Filiz O.
    Int Braz J Urol; 2017 Feb 01; 43(3):440-454. PubMed ID: 27583351
    [Abstract] [Full Text] [Related]

  • 12. Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 125 cases.
    Lim SD, Young AN, Paner GP, Amin MB.
    Virchows Arch; 2008 Jan 01; 452(1):49-55. PubMed ID: 18026989
    [Abstract] [Full Text] [Related]

  • 13. High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma.
    Ohba K, Miyata Y, Matsuo T, Asai A, Mitsunari K, Shida Y, Kanda S, Sakai H.
    Int J Clin Exp Pathol; 2014 Jan 01; 7(6):3158-65. PubMed ID: 25031735
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of CD44, platelet-derived growth factor receptor alpha, and cyclooxygenase 2 expression in renal cell carcinoma.
    Tawfik OW, Kramer B, Shideler B, Danley M, Kimler BF, Holzbeierlein J.
    Arch Pathol Lab Med; 2007 Feb 01; 131(2):261-7. PubMed ID: 17284111
    [Abstract] [Full Text] [Related]

  • 15. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.
    Rioux-Leclercq N, Turlin B, Bansard J, Patard J, Manunta A, Moulinoux JP, Guillé F, Ramée MP, Lobel B.
    Urology; 2000 Apr 01; 55(4):501-5. PubMed ID: 10736491
    [Abstract] [Full Text] [Related]

  • 16. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
    Zhang Y, Sun B, Zhao X, Liu Z, Wang X, Yao X, Dong X, Chi J.
    J Surg Oncol; 2013 Nov 01; 108(6):414-9. PubMed ID: 23996537
    [Abstract] [Full Text] [Related]

  • 17. Expression of CEACAM1 and CD105 in Renal Cell Carcinoma and Its Correlation with Microvessel Density.
    Kang ZP, Wang LX, Liu J, Ouyang H, Xie S, Tan Y.
    Crit Rev Eukaryot Gene Expr; 2021 Nov 01; 31(1):1-9. PubMed ID: 33639050
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic role of microvessel density in patients with renal cell carcinoma: a meta-analysis.
    Cheng SH, Liu JM, Liu QY, Luo DY, Liao BH, Li H, Wang KJ.
    Int J Clin Exp Pathol; 2014 Nov 01; 7(9):5855-63. PubMed ID: 25337227
    [Abstract] [Full Text] [Related]

  • 20. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.
    Visapää H, Bui M, Huang Y, Seligson D, Tsai H, Pantuck A, Figlin R, Rao JY, Belldegrun A, Horvath S, Palotie A.
    Urology; 2003 Apr 01; 61(4):845-50. PubMed ID: 12670587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.